Insider Shareholders with Direct Ownership of Black Diamond Therapeutics, Inc. (BDTX)
This section provides a comprehensive overview of the insiders with direct ownership of Black Diamond Therapeutics, Inc. (BDTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Black Diamond Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 4,781,993 | 0 | 8,517,839 $18.7 Million | 15 |
Oct 17, 2023
Added 4.49%
|
|
| 0 | 2,070,889 | 3,726,341 $8.16 Million | 27 |
Aug 28, 2024
Reduced 5.61%
|
|
| 14,500 | 73,000 | 671,423 $1.47 Million | 10 |
Jun 27, 2023
Reduced 3.59%
|
|
| 81,363 | 0 | 125,389 $274,601 | 3 |
Dec 22, 2022
Added 22.48%
|
|
| 63,334 | 0 | 63,334 $138,701 | 16 |
Dec 13, 2024
Added 8.32%
|
|
|
Mark A. Velleca
PRESIDENT & CEO |
46,522 | 0 | 46,522 $101,883 | 7 |
Sep 15, 2023
Added 10.07%
|
| 42,854 | 0 | 42,854 $93,850 | 10 |
Dec 16, 2022
Added 17.95%
|
|
| 37,168 | 0 | 38,054 $83,338 | 8 |
Mar 15, 2024
Added 7.88%
|
|
|
Bradley J Ph D Bolzon
Director |
13,144 | 0 | 21,851 $47,853 | 6 |
Dec 14, 2020
Added 0.05%
|
| 10,150 | 0 | 10,150 $22,228 | 2 |
Feb 13, 2023
Added 33.33%
|
|
| 10,145 | 0 | 10,145 $22,217 | 3 |
Dec 13, 2024
Added 33.67%
|
|
| 8,865 | 0 | 8,865 $19,414 | 3 |
Dec 13, 2024
Added 33.67%
|
|
| 45,524 | 40,124 | 8,400 $18,396 | 17 |
May 12, 2021
Reduced 4.01%
|
|
|
Christopher D. Roberts
Chief Scientific Officer |
28,200 | 25,000 | 3,200 $7,008 | 19 |
May 03, 2021
Reduced 43.86%
|
|
Thomas Leggett
Chief Financial Officer |
12,000 | 12,000 | 0 $0 | 8 |
Jan 08, 2021
Reduced 100.0%
|
| 443 | 443 | 0 $0 | 2 |
May 20, 2021
Reduced 100.0%
|